J&J Triumphs In First Prosima Trial
This article was originally published in The Gray Sheet
Executive Summary
A Dallas jury ruled in favor of Johnson & Johnson subsidiary Ethicon in a pelvic mesh product liability suit on Monday, marking a win in the first case to specifically involve the Prosima product.
You may also be interested in...
Jury Awards $12.5 Million In Damages In Ethicon Pelvic Mesh Case
The jury in the first pelvic mesh case to be heard in Philadelphia’s Court of Common Pleas found that Ethicon failed to warn physicians of the risks of Prolift Pelvic Mesh and that the mesh’s design was defective. It awarded the plaintiff $5.5 million in compensatory damages and $7 million in punitive damages. Ethicon plans to appeal.
J&J/Ethicon Begins Worldwide Withdrawal Of Vaginal Mesh Products
Firm is stopping sales of four of its vaginal mesh products in the face of over 1,000 product liability lawsuits and FDA requirements for post-market safety and efficacy studies.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.